BDNF in Neuropathic Pain; the Culprit that Cannot be Apprehended

• Published in: Neuroscience Vol. 543; pp. 49 - 64
• Main Author: Smith, Peter A.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 05.04.2024
• Subjects: allodynia; Animals; Brain-Derived Neurotrophic Factor - pharmacology; central sensitization; dorsal horn; Female; Hyperalgesia; Male; microglia; Neuralgia - drug therapy; neuropathy; Posterior Horn Cells; Rats; Rats, Sprague-Dawley; sex; Spinal Cord Dorsal Horn; BDNF; dorsal horn; sex; P2XR4; CCI; central sensitization; mIR1; CSF-1; IL-1 β; MAPK; allodynia; IFN-γ; TNF-α; Wnt3a; neuropathy; microglia
• ISSN: 0306-4522; 1873-7544
• DOI: 10.1016/j.neuroscience.2024.02.020

[Display omitted] •BDNF from microglia drives neuropathic pain.•Peripheral BDNF drives chronic inflammatory pain.•BDNF does not drive pain in females. In males but not in females, brain derived neurotrophic factor (BDNF) plays an obligatory role in the onset and maintenance of neuropathic pain. Afferent terminals of injured peripheral nerves release colony stimulating factor (CSF-1) and other mediators into the dorsal horn. These transform the phenotype of dorsal horn microglia such that they express P2X4 purinoceptors. Activation of these receptors by neuron-derived ATP promotes BDNF release. This microglial-derived BDNF increases synaptic activation of excitatory dorsal horn neurons and decreases that of inhibitory neurons. It also alters the neuronal chloride gradient such the normal inhibitory effect of GABA is converted to excitation. By as yet undefined processes, this attenuated inhibition increases NMDA receptor function. BDNF also promotes the release of pro-inflammatory cytokines from astrocytes. All of these actions culminate in the increase dorsal horn excitability that underlies many forms of neuropathic pain. Peripheral nerve injury also alters excitability of structures in the thalamus, cortex and mesolimbic system that are responsible for pain perception and for the generation of co-morbidities such as anxiety and depression. The weight of evidence from male rodents suggests that this preferential modulation of excitably of supra-spinal pain processing structures also involves the action of microglial-derived BDNF. Possible mechanisms promoting the preferential release of BDNF in pain signaling structures are discussed. In females, invading T-lymphocytes increase dorsal horn excitability but it remains to be determined whether similar processes operate in supra-spinal structures. Despite its ubiquitous role in pain aetiology neither BDNF nor TrkB receptors represent potential therapeutic targets.